Search Results for: HRAS

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
RASIP1 Ras interacting protein 1
RASSF1 Ras association domain family member 1
  • Non-small cell lung cancer
  • Bladder cancer
  • Nasopharyngeal cancer
RASSF2 Ras association domain family member 2
RASSF5 Ras association domain family member 5
RGL1 ral guanine nucleotide dissociation stimulator like 1
  • PPARA activates gene expression
  • RAF/MAP kinase cascade
RGL2 ral guanine nucleotide dissociation stimulator like 2
  • RAF/MAP kinase cascade
RGL4 ral guanine nucleotide dissociation stimulator like 4
RGS12 regulator of G protein signaling 12
  • G alpha (i) signalling events
  • G alpha (i) signalling events
RHOD ras homolog family member D
  • Rho GTPase cycle
  • RHO GTPases Activate Formins
RIN1 Ras and Rab interactor 1
  • RAB GEFs exchange GTP for GDP on RABs
RIT2 Ras like without CAAX 2
  • Signalling to p38 via RIT and RIN
RNF115 ring finger protein 115
  • Antigen processing: Ubiquitination & Proteasome degradation
RSPO3 R-spondin 3
  • Regulation of FZD by ubiquitination
  • RUNX1 regulates transcription of genes involved in WNT signaling
SHOC2 SHOC2 leucine rich repeat scaffold protein
  • RAF activation
  • Signaling by MRAS-complex mutants
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
SMAD4 SMAD family member 4
  • Signaling by NODAL
  • Signaling by Activin
  • Signaling by BMP
  • TGF-beta receptor signaling activates SMADs
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • SMAD4 MH2 Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Transcriptional regulation of pluripotent stem cells
  • Ub-specific processing proteases
  • RUNX2 regulates bone development
  • RUNX3 regulates CDKN1A transcription
  • RUNX3 regulates BCL2L11 (BIM) transcription
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • FOXO-mediated transcription of cell cycle genes
  • FOXO-mediated transcription of cell cycle genes
  • Colorectal cancer
  • Hereditary hemorrhagic telangiectasia (HHT)
  • Pancreatic cancer
  • Juvenile polyposis syndrome
SNRPE small nuclear ribonucleoprotein polypeptide E
  • SLBP independent Processing of Histone Pre-mRNAs
  • snRNP Assembly
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • RNA Polymerase II Transcription Termination
  • SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
SNX14 sorting nexin 14
SNX17 sorting nexin 17
SOS1 SOS Ras/Rac guanine nucleotide exchange factor 1
  • SOS-mediated signalling
  • SOS-mediated signalling
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB4 signaling
  • Signaling by SCF-KIT
  • Regulation of KIT signaling
  • Signalling to RAS
  • Signalling to RAS
  • GRB2 events in EGFR signaling
  • SHC1 events in EGFR signaling
  • Downstream signal transduction
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • GRB2 events in ERBB2 signaling
  • GRB2 events in ERBB2 signaling
  • Tie2 Signaling
  • EGFR Transactivation by Gastrin
  • DAP12 signaling
  • SHC-related events triggered by IGF1R
  • SHC-related events triggered by IGF1R
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • NCAM signaling for neurite out-growth
  • G alpha (12/13) signalling events
  • Activation of RAC1
  • Constitutive Signaling by EGFRvIII
  • SHC-mediated cascade:FGFR1
  • FRS-mediated FGFR1 signaling
  • SHC-mediated cascade:FGFR2
  • FRS-mediated FGFR2 signaling
  • SHC-mediated cascade:FGFR3
  • FRS-mediated FGFR3 signaling
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • RAF/MAP kinase cascade
  • Signal attenuation
  • Insulin receptor signalling cascade
  • Insulin receptor signalling cascade
  • MET activates RAS signaling
  • Signaling by FGFR3 fusions in cancer
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Interleukin-15 signaling
  • Activated NTRK2 signals through RAS
  • Erythropoietin activates RAS
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK3 signals through RAS
  • Interleukin receptor SHC signaling
  • FLT3 Signaling
  • Constitutive Signaling by Overexpressed ERBB2
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 ITD and TKD mutants
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
SOS2 SOS Ras/Rho guanine nucleotide exchange factor 2
  • NRAGE signals death through JNK
  • Rho GTPase cycle
  • G alpha (12/13) signalling events
  • Activation of RAC1
  • Interleukin-15 signaling

Page 7 out of 8 pages